Medical Biotechnology and Molecular Medicine ((Classe LM-9)-Enrolled from 2016/17 Academic Year
Master programme
A.Y. 2019/2020
LM-9 - Biotecnologie mediche, veterinarie e farmaceutiche (EN)
The Master Program in Medical Biotechnology and Molecular Medicine is committed to form professionals, provided with a strong technical and theoretical background. The expected evolution of their careers will be to develop scientific methodologies and coordinate research projects in the fields of applied biotechnology and translational medicine. The Master Program will provide students with a strong educational background on the genetic and molecular bases of diseases and the pathophysiological mechanisms that take place in the sick human organism, in order to develop diagnostic and therapeutic strategies based on biotechnology. This knowledge will be integrated with a specific formation in the fields of informatics, biophysics, nanotechnology and pharmacology. The Master Program is organized in common and curricular learning activities with insights into neuroscience, oncology, molecular diagnostics and immunobiotechnology. As a part of the common course, the students will learn about economic management of a scientific project, with emphasis on the construction of the business plan and cost analysis. The Master Program dedicates a long period of time, almost the entire second year, to laboratory activities in which the student, under the supervision of a tutor, will autonomously develop different experimental approaches in the context of a wider research project. This activity will be finalized to the preparation of the degree program final exam.
Researcher in the fields of medical biotechnology and molecular medicine
Tasks: to develop new experimental models for the study of human diseases, to develop new diagnostic approaches, to identify new therapeutic molecules, to devise innovative drug delivery systems.
Competences: this professional has a strong medical educational background that will allow him to create interfaces with the clinics, being a bridge between the bench side and the bedside. A deep knowledge of the pathogenetic mechanisms of diseases is required in order to apply basic disciplines to the resolution of medical problems.
Employment opportunities: public and private research structures, including University, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health), Hospitals, private pharmaceutical, diagnostics and biotechnological companies, companies supporting science research (instruments, biotechnological reagents an so on).
Medical Science Liaison (MSL)
Tasks: in the pharmaceutical and biotechnological companies, this new professional has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company.
Competences: this professional has a strong medical and pharmacological background that enable him to talk together with physicians in order to solve clinical problem related to the use of specific drugs.
Employment opportunities: pharmaceutical and biotechnological companies.
Clinical Monitor
Tasks: to coordinate clinical studies.
Competences: strong background in pharmacology and statistics.
Employment opportunities after a specific training course: pharmaceutical and biotechnological companies; CRO (Clinical Research Organization).
Market Access Manager
Tasks: to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products. To work inside Regulatory Authorities (e.g. AIFA)
Competences: this professional has a background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs.
Employment opportunities after a specific training course: pharmaceutical and biotechnological companies; consultant, AIFA (italian agency for drugs).
Medical and scientific communication advisor
Tasks: medical writer; consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education. Advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
Competences: multidisciplinary approaches to medical sciences.
Employment opportunities: medical communication agencies.
The graduates in the Master Program in Medical Biotechnology and Molecular Medicine will have access to PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
Tasks: to develop new experimental models for the study of human diseases, to develop new diagnostic approaches, to identify new therapeutic molecules, to devise innovative drug delivery systems.
Competences: this professional has a strong medical educational background that will allow him to create interfaces with the clinics, being a bridge between the bench side and the bedside. A deep knowledge of the pathogenetic mechanisms of diseases is required in order to apply basic disciplines to the resolution of medical problems.
Employment opportunities: public and private research structures, including University, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health), Hospitals, private pharmaceutical, diagnostics and biotechnological companies, companies supporting science research (instruments, biotechnological reagents an so on).
Medical Science Liaison (MSL)
Tasks: in the pharmaceutical and biotechnological companies, this new professional has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company.
Competences: this professional has a strong medical and pharmacological background that enable him to talk together with physicians in order to solve clinical problem related to the use of specific drugs.
Employment opportunities: pharmaceutical and biotechnological companies.
Clinical Monitor
Tasks: to coordinate clinical studies.
Competences: strong background in pharmacology and statistics.
Employment opportunities after a specific training course: pharmaceutical and biotechnological companies; CRO (Clinical Research Organization).
Market Access Manager
Tasks: to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products. To work inside Regulatory Authorities (e.g. AIFA)
Competences: this professional has a background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs.
Employment opportunities after a specific training course: pharmaceutical and biotechnological companies; consultant, AIFA (italian agency for drugs).
Medical and scientific communication advisor
Tasks: medical writer; consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education. Advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
Competences: multidisciplinary approaches to medical sciences.
Employment opportunities: medical communication agencies.
The graduates in the Master Program in Medical Biotechnology and Molecular Medicine will have access to PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
Transfer requirements
To be admitted to the entrance test, the candidates have to possess 180 ects obtained in the Bachelor's degree, of which 50 in the following sectors: BIO/09 (Physiology), BIO/10 (Biochemistry), BIO/11 (Molecular biology), BIO/12 (Clinical biochemistry), BIO/13 (Biology), BIO/14 (Pharmacology), BIO/16 (Human anatomy) , BIO/18 (Genetics), BIO/19 (General microbiology), MED/01 (Medical statistics), MED/03 (Human genetics), MED/04 (General pathology and immunology), MED/05 (Clinical pathology), MED/06 (Medical oncology), MED/07 (Microbiology), MED/08 (Pathology), MED/09 (Internal medicine), MED/25 (Mental health), MED/26 (Neurology), MED/46 (Laboratory medicine), INF/01 (Informatics), FIS/07 (Medical physics).
In order to profitably follow the learning activities, the candidate should have a good knowledge of spoken and written English. The B2 level is required and the certification has to be provided at the registration of the admission test.
Students waiting for obtaining the Bachelor's Degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they will obtain the Bachelor degree by December 31th, also possessing the prerequisite described above.
In order to profitably follow the learning activities, the candidate should have a good knowledge of spoken and written English. The B2 level is required and the certification has to be provided at the registration of the admission test.
Students waiting for obtaining the Bachelor's Degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they will obtain the Bachelor degree by December 31th, also possessing the prerequisite described above.
The Master programme in Medical Biotechnology and Molecular Medicine supports cooperation opportunities and mobility with leading international universities, as well as the possibility for students to earn credits through exchange education and training programmes with Partner organizations.
Bilateral agreements with the University of Leuven (Katolieke Universiteit Leuven, Belgium), the LUMC (Leids Universitair Medish Centrum) of the University of Leiden (Netherland) and the University of Cantabria (Universidad de Cantabria, Spain) are and have been active for several years in the framework of the Erasmus + programme. In recent years, a growing number of students have developed their professionalism and the European dimension of their training through residence periods abroad. Associated universities represent highly recognized European institutions, featuring reference schools (Master and PhD schools) in biomedical sciences. The students will thus be offered exciting opportunities to enhance their CVs and evaluate their interests in extending their careers in the international setting.
5 positions are available for the Academic Year 2019-2020. The Master course in Medical Biotechnology and Molecular Medicine offers second year students the possibility to carry out the entire practical training for the preparation of their final thesis work in one of the aforementioned institutions or with other institutions with which an agreement has been established. The student will have to define a research project related to his/her course of studies and curricular training, with the joint agreement of both the Unimi and the foreign tutors. The period abroad amounts to 9 months equivalent to 32 credits. A positive evaluation of the period abroad will be required. The latter should be defined by the tutor in the foreign university, the UNIMI tutor and is subjected to the approval by the Unimi Didactic Council. Erasmus students who obtain outstanding results, proved by an official evaluation letter of the foreign tutor to the President of the Masters Commission, will be rewarded with 1-2 additional point sin the final Laurea Grade.
Besides general informative meetings organized by the University, The Degree course in Medical Biotechnology provides specific support to interested students. Furthermore, the international programme provides the possibility to access the Erasmus + programme.
Bilateral agreements with the University of Leuven (Katolieke Universiteit Leuven, Belgium), the LUMC (Leids Universitair Medish Centrum) of the University of Leiden (Netherland) and the University of Cantabria (Universidad de Cantabria, Spain) are and have been active for several years in the framework of the Erasmus + programme. In recent years, a growing number of students have developed their professionalism and the European dimension of their training through residence periods abroad. Associated universities represent highly recognized European institutions, featuring reference schools (Master and PhD schools) in biomedical sciences. The students will thus be offered exciting opportunities to enhance their CVs and evaluate their interests in extending their careers in the international setting.
5 positions are available for the Academic Year 2019-2020. The Master course in Medical Biotechnology and Molecular Medicine offers second year students the possibility to carry out the entire practical training for the preparation of their final thesis work in one of the aforementioned institutions or with other institutions with which an agreement has been established. The student will have to define a research project related to his/her course of studies and curricular training, with the joint agreement of both the Unimi and the foreign tutors. The period abroad amounts to 9 months equivalent to 32 credits. A positive evaluation of the period abroad will be required. The latter should be defined by the tutor in the foreign university, the UNIMI tutor and is subjected to the approval by the Unimi Didactic Council. Erasmus students who obtain outstanding results, proved by an official evaluation letter of the foreign tutor to the President of the Masters Commission, will be rewarded with 1-2 additional point sin the final Laurea Grade.
Besides general informative meetings organized by the University, The Degree course in Medical Biotechnology provides specific support to interested students. Furthermore, the international programme provides the possibility to access the Erasmus + programme.
The student is required to attend all the teaching activities, with a tolerance of no more than 25% of the hours.
Students are required to sign their attendance at each learning activities. Should the number of absences be higher than 25%, the Teaching Committee will take the necessary measures.
Students are required to sign their attendance at each learning activities. Should the number of absences be higher than 25%, the Teaching Committee will take the necessary measures.
Courses list
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | |||
| - Internal medicine | 6 | |||
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | |||
| - Medical genetics | 6 | |||
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Molecular diagnostics and therapy | 6 | 42 | English | BIO/14 MED/26 MED/36 |
| - Neurology | 2 | |||
| - Pharmacology | 3 | |||
| - Radiology | 1 | |||
| Neurobiology | 6 | 42 | English | BIO/09 BIO/10 BIO/14 MED/26 |
| - Biochemistry | 1 | |||
| - Neurology | 1 | |||
| - Pharmacology | 1 | |||
| - Physiology | 3 | |||
| Pathogenetic bases of neurological and psychiatric disorders | 6 | 42 | English | BIO/11 MED/13 MED/25 MED/26 |
| - Endocrinology | 1 | |||
| - Mental health | 2 | |||
| - Molecular biology | 1 | |||
| - Neurology | 2 | |||
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | |||
| - History of medicine | 6 | |||
Open sessions
There are no specific sessions for these activities (e.g. open online courses).
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | |||
| - Internal medicine | 6 | |||
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | |||
| - Medical genetics | 6 | |||
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer immunology (ONC) | 6 | 42 | English | MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | |||
| - General pathology and immunology | 2 | |||
| - Medical oncology | 2 | |||
| Epidemiology, pathogenesis and diagnostics of cancer | 6 | 42 | English | MED/01 MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | |||
| - General pathology and immunology | 1 | |||
| - Medical Oncology | 2 | |||
| - Medical statistics | 1 | |||
| Research and development of new diagnostic and therapeutic metodologies | 6 | 42 | English | BIO/11 MED/08 MED/15 MED/36 |
| - Blood diseases | 2 | |||
| - Molecular biology | 2 | |||
| - Pathology | 1 | |||
| - Radiology | 1 | |||
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | |||
| - History of medicine | 6 | |||
Open sessions
There are no specific sessions for these activities (e.g. open online courses).
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | |||
| - Internal medicine | 6 | |||
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | |||
| - Medical genetics | 6 | |||
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced techniques in medical biotechnology | 6 | 42 | English | BIO/10 BIO/11 BIO/13 MED/40 |
| - Biochemistry | 2 | |||
| - Biology | 2 | |||
| - Molecular biology | 1 | |||
| - Obstetrics and gynecology | 1 | |||
| Data and laboratory management | 6 | 42 | English | MED/01 MED/05 MED/43 MED/46 |
| - Clinical pathology | 2 | |||
| - Forensic medicine | 2 | |||
| - Laboratory medicine | 1 | |||
| - Medical statistics | 1 | |||
| Molecular diagnostics | 6 | 42 | English | BIO/12 MED/03 MED/07 |
| - Clinical biochemistry | 2 | |||
| - Human genetics | 2 | |||
| - Microbiology | 2 | |||
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | |||
| - History of medicine | 6 | |||
Open sessions
There are no specific sessions for these activities (e.g. open online courses).
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | |||
| - Internal medicine | 6 | |||
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | |||
| - Medical genetics | 6 | |||
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer immunology (IMM) | 6 | 42 | English | MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | |||
| - General pathology and immunology | 2 | |||
| - Medical oncology | 2 | |||
| Experimental immunology and immunobiotechnology | 6 | 42 | English | MED/04 MED/16 MED/46 VET/05 |
| - Domestic animal infectious diseases | 2 | |||
| - General pathology and immunology | 1 | |||
| - Laboratory medicine | 2 | |||
| - Reumatology | 1 | |||
| Transplantation and tissue engineering | 6 | 51 | English | ING-IND/34 MED/15 MED/18 MED/43 |
| - Blood diseases | 1 | |||
| - Forensic medicine | 1 | |||
| - General surgery | 3 | |||
| - Industrial bioengineering | 1 | |||
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | |||
| - History of medicine | 6 | |||
Open sessions
There are no specific sessions for these activities (e.g. open online courses).
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
Course location
Milano
Presidente del Collegio Didattico
professoressa Maura Francolini
Tutors professors
Reference structures
Contacts
- - professor Anna Marozzi (curriculum Molecular diagnostics for personalized medicine)
[email protected] - - professor Diego Maria Fornasari (curriculum Neuroscience)
[email protected] - - professor Antonino Neri (curriculum Medical and experimental oncology)
[email protected] - - professor Massimo Locati and professor Mariano Ferraresso (curriculum Experimental immunology and transplantations)
[email protected] - [email protected] - - Student secretary: Mrs Lucia Loseto
Dip. Biotecnologie Mediche e Medicina Traslazionale sede di via Vanvitelli, 32
[email protected]
+390250317123 - Application and enrolment information and procedures
http://www.unimi.it/studenti/matricole/77650.htm
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
A.Y. 2020/2021
A.Y. 2019/2020
A.Y. 2018/2019
Official documents